Global Nanobodies Market Report By Product Type (Mono-specific, Monovalent, Multivalent, Bi-paratopic, Multi-specific), By Indication (Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Respiratory Syncytial Virus (RSV) Infection, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Immune Mediated Inflammatory Diseases (IMID), Psoriasis, Chronic Kidney Diseases, Bone Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Nanobodies Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212702

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Nanobodies Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Nanobodies are a novel class of proprietary therapeutic proteins based on single-domain antibody fragments. It contains the unique structural and functional properties of naturally-occurring heavy-chain antibodies. These are small, recombinantly produced antigen-binding VHH fragments, derived from the Alpaca heavy chain IgG antibody (HCA). Due to their tiny size and unique structure, Nanobodies are ideal building blocks for the generation of novel biological drugs with multiple competitive advantages over other therapeutic molecules. The most common uses of nanobodies are for experiments like immunoprecipitation, or fluorescence microscopy.

Market Dynamics

The growing biologics and therapeutic research and FDA approval provide many opportunities to investigate nanobodies and their interaction with others, thereby lifting hopes for exploring innovative uses. In recent years, nanobodies have become indispensable therapeutic and research tools due to the growing burden of cancer, immune-mediated inflammatory and other diseases. Nanobodies is a lucrative approach for oncology therapeutics research as it inhibits tumor growth, protects the body against systemic toxicity, and allows solubilization of hydrophobic drug in hydrophilic structures. They are researched against a diverse range of disorders and capable of being employed in various situations. Recognizing the potential, companies engaged in therapeutic research are adopting different collaborative research strategies to develop and commercialize nanobody-based therapeutics.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of nanobodies.

Market Segmentation

The entire nanobodies market has been sub-categorized into product type, indication and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product Type

Mono-specific
Monovalent
Multivalent
Bi-paratopic
Multi-specific

By Indication

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Respiratory Syncytial Virus (RSV) Infection
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Oncology
Immune Mediated Inflammatory Diseases (IMID)
Psoriasis
Chronic Kidney Diseases
Bone Disorders
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for nanobodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Nanobodies Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nanobodies market include Novo Nordisk A/S, Merck & Co., Inc., Merck KgaA, AbbVie, Inc., C.H. Boehringer Sohn AG & Ko. KG., Ablynx. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Nanobodies Market
       2.2. Global Nanobodies Market Snapshot

3 . NANOBODIES – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Nanobodies Market
       3.3. Market Restraints of Nanobodies Market
       3.4. Opportunities of Nanobodies Market
       3.5. Trends of Nanobodies Market
       3.6. Porter’s Five Force Analysis of Nanobodies Market
       3.7. Nanobodies Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product Type
           3.7.2 Market Attractive Analysis by Indication
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Nanobodies Value Chain Analysis
       4.2. Nanobodies Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Nanobodies Raw Material Manufactures List
           4.2.3. Price Trend of Nanobodies Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Nanobodies Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Nanobodies Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Nanobodies Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Nanobodies Market

6 . GLOBAL NANOBODIES MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical Data 2015-2018
       6.3 Global Nanobodies Market Analysis by Product Type
       6.4 Market Analysis of Mono-specific by Regions
       6.6 Market Analysis of Monovalent by Regions
       6.5 Market Analysis of Multivalent by Regions
       6.7 Market Analysis of Bi-paratopic by Regions
       6.8 Market Analysis of Multi-specific by Regions

7 . GLOBAL NANOBODIES MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical Data 2015-2018
       7.3 Global Nanobodies Market Analysis by Indication
       7.4 Market Analysis of Acquired Thrombotic Thrombocytopenic Purpura (aTTP) by Regions
       7.5 Market Analysis of Respiratory Syncytial Virus (RSV) Infection by Regions
       7.6 Market Analysis of Rheumatoid Arthritis by Regions
       7.7 Market Analysis of Systemic Lupus Erythematosus by Regions
       7.8 Market Analysis of Oncology by Regions
       7.9 Market Analysis of Immune mediated Inflammatory Diseases (IMID) by Regions
       7.10. Market Analysis of Psoriasis by Regions
       7.11 Market Analysis of Chronic Kidney Diseases by Regions
       7.12 Market Analysis of Bone Disorders by Regions
       7.13 Market Analysis of Others by Regions

8 . GLOBAL NANOBODIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical Data 2015-2018
       8.3 Global Nanobodies Market Analysis by Distribution Channel
       8.4 Market Analysis of Hospital Pharmacies by Regions
       8.5 Market Analysis of Retail Pharmacies by Regions
      8.6 Market Analysis of Online Pharmacies by Regions

9 . GLOBAL NANOBODIES MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Nanobodies Market Estimate By Market Segment
           9.3.3. North America Nanobodies Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Nanobodies Market Estimate by Market Segment
           9.4.3. Europe Nanobodies Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Nanobodies Market Estimate by Market Segment
           9.5.3. Asia Pacific Nanobodies Market Estimate by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Nanobodies Market Estimate by Market Segment
           9.6.3. Latin America Nanobodies Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Nanobodies Market Estimate by Market Segment
           9.7.3. Middle East & Africa Nanobodies Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE NANOBODIES COMPANIES
       10.1. Nanobodies Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 . COMPANY PROFILES OF NANOBODIES INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Novo Nordisk A/S
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Merck & Co., Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Merck KgaA
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. AbbVie, Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. C.H. Boehringer Sohn AG & Ko. KG.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Ablynx
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments

*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Nanobodies Report
Market Research Process
Market Research Methodology
Global Nanobodies Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product Type
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Nanobodies Market Analysis by Product Type
Global Nanobodies Market Analysis in Mono-specific by Region
Global Nanobodies Market Analysis in Monovalent by Region
Global Nanobodies Market Analysis in Multivalent by Region
Global Nanobodies Market Analysis in Bi-paratopic by Region
Global Nanobodies Market Analysis in Multi-specific by Region
Global Nanobodies Market Analysis by Indication
Global Nanobodies Market Analysis in Acquired Thrombotic Thrombocytopenic Purpura (aTTP) by Region
Global Nanobodies Market Analysis in Respiratory Syncytial Virus (RSV) Infection by Region
Global Nanobodies Market Analysis in Rheumatoid Arthritis by Region
Global Nanobodies Market Analysis in Systemic Lupus Erythematosus by Region
Global Nanobodies Market Analysis in Oncology by Region
Global Nanobodies Market Analysis in Immune mediated Inflammatory Diseases (IMID) by Region
Global Nanobodies Market Analysis in Psoriasis by Region
Global Nanobodies Market Analysis by Distribution Channel
Global Nanobodies Market Analysis in Hospital Pharmacies by Region
Global Nanobodies Market Analysis in Retail Pharmacies by Region
Global Nanobodies Market Analysis in Online Pharmacies by Region
Global Nanobodies Market by Revenue
North America Nanobodies Market by Revenue
Europe Nanobodies Market by Revenue
Asia Pacific Nanobodies Market by Revenue
Latin America Nanobodies Market by Revenue
Middle East & Africa Nanobodies Market by Revenue
Recent Development in Nanobodies Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "